title: Editorial comment from Dr Funahashi to α1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: efficacy of dose increase therapy.
authors.affiliation: Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan. funa418@yahoo.co.jp
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Funahashi
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009281:Naphthalenes / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D014555:Urination Disorders / Q000188:drug therapy*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D009281:Naphthalenes; D010879:Piperazines; C064357:naftopidil